To confirm the role of AHR signaling in ASD susceptibility, we treated control rats with an AHR inhibitor (CH-223191) and IUGR rats with an AHR agonist (ITE) at PW4-6 (Fig. 2D). Here, AHR is linked to fetal growth restriction.